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Introduction. Primary melanoma of the urinary bladder is very rare. As far as we know, 19 cases have been reported worldwide,
usually as case reports. Case Presentation. We present a 71-year-old male patient presented with a 2-month history of hematuria.
Ultrasonographyrevealeda5-cm-sizemasslocatedinthebladdertrigone.Atransurethralresectionofthebladdertumor(TURBT)
revealed a malignant melanoma. Evaluation for metastatic disease was negative. The patient deceased ﬁve months later before
radical treatment could be performed. Conclusion. This is one more reported case of primary melanoma of the urinary bladder.
The previously reported cases of bladder melanoma are reviewed. Therapy and prognosis are discussed.
1.Introduction
Malignant melanoma originating from the urinary bladder
is very rare although urethral melanoma has been well de-
scribed [1]. Melanoma of the bladder is most commonly sec-
ondary presentation of patients with widespread metastatic
melanoma originating from the skin. Exclusion of other
melanoma sites is mandatory to conﬁrm primary bladder
melanoma.
2. Case History
A71-year-oldMoroccanmalepresentedwitha2monthshis-
tory of gross hematuria. There was no past history of calcu-
lous disease or ﬂank pain. He had been smoking 50 cigarettes
a day for the past 40 years. There was no history of contact
with aniline dyes or other chemicals. The physical and
paraclinical examinations were normal. Ultrasonography re-
vealeda5-cm-sizeheterogeneousmasslocatedinthebladder
trigone. Cystoscopy showed a 50 × 40 × 10mm darkly
pigmented ﬂat papillary lesion of the bladder trigone. A deep
transurethral resection of the bladder has been, therefore,
performed. The resection specimen examination showed
pigmented malignant melanoma (Figures 1 and 2). Exhaus-
tive investigation was undertaken to exclude other primary
sites as the source of the melanoma. Careful dermatologic
examination including a Wood’s light examinations of the
whole body and ophthalmologic evaluations were negative.
Upper gastrointestinal and barium enema studies were neg-
ative. CT scan of the abdomen, including liver and spleen,
wasnormal,aswasCTscanofthebrainandchest.Bonescan
wasnegative. Thediagnosis ofprimarymalignantmelanoma
of the urinary bladder was made. The patient deceased ﬁve
months later before any radical treatment could be per-
formed.
3. Discussion
Malignantmelanomaofthegenitourinarytracthasbeenwell
documented. It is most commonly secondary to melanoma
occurring in other sites. Numerous cases of primary mela-
noma of the urinary bladder have been previously reported.
In such cases, a detailed patient history, careful examination
of the patient’s skin, and evaluation for other visceral
primary sites are necessary to conﬁrm the primary nature of
the tumor [2].
The histogenesis of primary bladder melanoma is uncer-
tain, and an origin from cells of the neural crest has been
proposed [3].
In1976,Ainsworthandassociatesweretheﬁrstobservers
to carefully delineate criteria for deﬁning primary malig-
nant melanoma of the urinary bladder. These include (1)2 Case Reports in Urology
Figure 1: Section of tumor mass shows pigmented malignant
melanocytes (HES ×20).
Figure 2: Tumor cells showing positive immunostaining to PS100
(HES ×20).
careful physical examination including the skin with Wood’s
light together with detailed history to exclude cutaneous
melanoma, (2) exclusion of visceral melanoma following
exhaustive evaluation, (3) pattern of recurrence consistent
with primary melanoma of the urinary bladder, and (4) his-
tologically proved primary atypical melanocytes [2].
Wheelock [4] was the ﬁrst to report a primary melanoma
of the bladder in 1942, then Su reported one case in 1962,
followed by Anichkov and Nikonov [5] who reported 2
cases of primary bladder melanoma but in neither case were
exhaustive studies undertaken to exclude other sites’ pri-
mary melanoma [6–8]. The primary bladder melanoma
is extremely rare, and probably none of those previously
reported cases truly arose from the bladder.
Sev e raltr eatme ntsw e r ep r o posedt od ealwiths uc harar e
tumor. Transurethral resection, partial cystectomy, radical
cystectomy, chemotherapy, and radiation therapy have been
used to treat bladder melanoma [2, 6, 8, 9]. In all patients
with localised tumor, radical surgery seems to be the therapy
of choice, although to date none of the patients survived
more than three years despite cystectomy characterizing
the poor prognosis of the tumor [2, 6, 8, 9]. Since the
tumor recur after local excision in many cases, adjuvant
chemotherapy associated with radiotherapy may improve
patients’ survival [10]. Interferon is another alternative for
the management of melanoma and showed 10% remission
rate in metastatic cutaneous melanomas [11].
Despite this variety of treatments, the prognosis is bad.
Ainsworth’s patient was treated with radical cystectomy fol-
lowed by chemotherapy and radiotherapy and developed
local recurrence after 14 months [2]. In 2006, Pacella
et al. reported an 82-year-old patient who presented a
local recurrence and died nine months after the diagnosis.
Lately, our patient died of widespread disease two months
after diagnosis. However, Neiderberger reported 18 months
disease-free survival in a primary bladder melanoma patient
treated with radical cystectomy alone [8].
In all reported cases, the tumor was deeply invading the
muscle which may explain the very bad prognosis [2, 6, 9].
4. Conclusion
Melanomaofthebladderismostcommonlyasecondarypre-
sentation of patients with widespread metastatic melanoma
originating from the skin. We have shown that primary
melanomaofthebladderisextremelyrare,andallthecriteria
reported by Ainsworth should be met to conﬁrm the diagno-
sis [2]. Treatment of the primary melanoma of the bladder
should include radical surgery. The prognosis is guarded.
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